🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

This will be the interview of the decade! The corruption exposed by this eye-popping interview is the cancer destroying our great nation! Donald J. Trump JD Vance Robert F. Kennedy Jr President Donald J. Trump Elon Musk Dr. Pat Soon-Shiong Tucker Carlson Vivek Ramaswamy x.com/TuckerCarlson/…

SeanBoss C Lebovits Dr. Marty Makary C Lebovits, surprise us by breaking your silence. It's way overdue and please pay some respect to pALS who fought and still do for Nurown approval. Do you have anything to do with that?

Pretty impressive that one of the world's top #Parkinsons neurologists counts his work to develop #NurOwn among his top three lifetime achievements. Dr. Melamed clarified why stem cells must be enhanced to optimize efficacy in neurons: "There's been a lot of hype about stem

Just sharing this man (Justin) and his beautiful family's story with ImmunityBio's Anktiva (BioShield). He and his amazing Doctors are an inspiration to all. THIS NEEDS TO BE AVAILABLE, AS A CHOICE TO ALL NOW! PLEASE SHARE!!! ImmunityBio, Inc. Dr. Pat Soon-Shiong Dr. Marty Makary

It is unbelievable what Dr. Pat Soon-Shiong is achieving. He is single-handedly making the world know about ImmunityBio, Inc. and the BioShield which seems to be our best hope against CANCER, COVID, AND HIV. (and some more nasty things) Dr. Pat is doing that by constantly speaking to a

How Wall Street short sellers worked with the media and federal prosecutors to destroy Trevor Milton’s company and put him in jail for life. This is a shocking story. (0:00) Introduction (0:31) The Origins of Milton’s Hydrogen Truck Company Nikola (4:17) What Is a Hydrogen

Thankfully I do not have cancer but if I did or if anyone I knew did I would call $ibrx immediately and not hang up until I had an appointment! To aggressive? Cancer is more aggressive! ❤️ Dr. Pat Soon-Shiong Robert F. Kennedy Jr

We need bioshield ANKTIVA by ImmunityBio, Inc. to clear the remnant of COVID or Vaccine SP. it has been tested and proven to be effective without no side effects Dr. Pat Soon-Shiong Dr. Marty Makary Secretary Kennedy $IBRX

Kade's treating #neurologist imploring U.S. FDA & FDA Biologics to approve #NurOwn as she watched it work on Kade & other patients. Now survival data & RWD in medical records proved it worked. accessnewswire.com/newsroom/en/he… Dr. Marty Makary Vinay Prasad MD MPH Secretary Kennedy Kade knew #NurOwn

Just received this text yesterday from my friend Joe who saw the video on Anktiva "I'm almost in tears, Justin has been my friend for decades. Thank you so very much" Anktiva, the Cancer Bioshield. This is why we do what we do.

U.S. FDA Dr. Marty Makary Please make #BioShield #Anktiva widely available/accessible for those battling cancer. It’s the difference of life and death for those who could be treated now with this. What’s the hold up? Is it not better to at least consider compassionate use protocols

Hello Dr. Marty Makary, you are the boss of the FDA. I am well aware that this is a new situation for the FDA: for the first time in history there is a drug that seems to be able to cure cancer. There are 10+ years survivors that took part in early trials of ImmunityBio, Inc.. Even

We’ve reported a 60% revenue increase in Q2 2025, with year-to-date sales reaching $43M and a 246% growth in ANKTIVA® sales since J-code issuance. Regulatory milestones continue to help us advance our mission of improving outcomes for patients. Read more: immunitybio.com/immunitybio-re…

x.com/i/grok/share/B… Grok analyze #IBRX Revenue growing exponentially < > 100mil just thinking USA, UK? Thinking maybe last offering or another, depending one growing revenue. Dr. Pat Soon-Shiong get another advisory team you could be a 10 dlls stock price by now.

Awesome to see new entrepreneurs breaking the status quo, and helping retail investors. 👋

I have heard this before #CLOVER Albert Alan @

We will all find out soon. The previous administration completely ignored and missed the point on #NurOwn. They based their decision on outdated regulatory guidance and an endpoint that is incapable of showing full functional improvement and stability. Vinay is reviewing it now.